Search Press releases Keywords From To 2 Oct 2020 Changes in UCB's Board of Directors Read More 25 Sep 2020 Disposals of own shares Read More 22 Sep 2020 UCB Achieves Important Regulatory Milestone for Bimekizumab Read More 11 Sep 2020 Disposals of own shares Read More 9 Sep 2020 Final Phase II Results for UCB’s Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) Published in Blood Advances Read More 4 Sep 2020 Disposals of own shares Read More Pagination First page Previous page Previous … Page 53 Page 54 Page 55 Page 56 Current page 57 Page 58 Page 59 Page 60 Page 61 … Page 57 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
